WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

Search

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

8.13 -0.61

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

8.01

Max

8.26

Schlüsselkennzahlen

By Trading Economics

Einkommen

-8.2M

-15M

Verkäufe

2.6M

35M

KGV

Branchendurchschnitt

201.137

27.852

EPS

-0.253

Gewinnspanne

-42.012

Angestellte

524

EBITDA

-5.5M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+9.89% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

22. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

81M

255M

Vorheriger Eröffnungskurs

8.74

Vorheriger Schlusskurs

8.13

Nachrichtenstimmung

By Acuity

17%

83%

6 / 150 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Juli 2025, 15:46 UTC

Wichtige Markttreiber

BitMine Shares Fall After Closing of $250 Million Private Placement

9. Juli 2025, 23:44 UTC

Market Talk

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9. Juli 2025, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Juli 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9. Juli 2025, 22:59 UTC

Market Talk

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9. Juli 2025, 22:59 UTC

Market Talk

Global Equities Roundup: Market Talk

9. Juli 2025, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juli 2025, 20:26 UTC

Ergebnisse

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9. Juli 2025, 19:18 UTC

Market Talk

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9. Juli 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9. Juli 2025, 18:31 UTC

Market Talk

Some Fed Officials Supported Considering July Cut -- Market Talk

9. Juli 2025, 17:07 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9. Juli 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk -2-

9. Juli 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Juli 2025, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. Juli 2025, 16:14 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Juli 2025, 16:14 UTC

Market Talk

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9. Juli 2025, 16:14 UTC

Akquisitionen, Fusionen, Übernahmen

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9. Juli 2025, 16:12 UTC

Market Talk

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9. Juli 2025, 16:08 UTC

Market Talk

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9. Juli 2025, 15:31 UTC

Wichtige Markttreiber

BitMine Shares Fall After Closing of $250M Private Placement

9. Juli 2025, 15:31 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9. Juli 2025, 15:27 UTC

Market Talk

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9. Juli 2025, 14:36 UTC

Akquisitionen, Fusionen, Übernahmen

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9. Juli 2025, 14:31 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9. Juli 2025, 14:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

9. Juli 2025, 14:26 UTC

Market Talk

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

9.89% Vorteil

12-Monats-Prognose

Durchschnitt 9 USD  9.89%

Hoch 9 USD

Tief 9 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

2

Buy

0

Halten

0

Sell

Stimmung

By Acuity

6 / 150 Ranking in Konsumgüter defensiv

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.